Strategic Partnerships Opportunity exists in expanding partnerships around infusion pump development and subcutaneous delivery for PAH, leveraging Mainbridge’s work with Liquidia and Sandoz to approach more pharma companies seeking specialized Buy and Bill and specialty pharmacy workflows.

Healthcare Tech Stack Target buyers can be engaged around FUSEBOX and the health system tools for oncology centers and specialty pharmacies, highlighting potential for integration with existing hospital IT ecosystems and improving supply chain management.

Market Positioning Position Mainbridge as a niche enabler for payor and provider alignment in complex therapies, emphasizing the unique ability to support Buy and Bill practices and Specialty Pharmacy operations within PAH and related acute care segments.

Growth Signals Financials show a scalable, mid-market footprint with room to grow; pursue mid-tier health systems and specialty networks that require interoperable solutions and infusion therapy workflow optimization.

Competitive Edge Differentiate by offering collaborative R&D pathways with pharma partners and contract manufacturers, using existing momentum with Liquidia and Sandoz to accelerate pilots and proof-of-concept deployments.